Verastem

formerly Verastem OncologyIPO

Verastem is a biotech company in Boston, United States, founded in 2010. It has raised $392.5M across 8 rounds, most recently a $90.0M Corporate Round in November 2025.

Precision targeting of RAS/MAPK pathway-driven cancers

Employees
51–200
Founded
2010
Business Model
B2B
Total Funding
$392.5M
Last Round
$90.0M Corporate RoundNov 2025
Rounds
8
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 8 funding rounds and 5 investors for this company. The full record is or through the API.

About

Verastem Oncology is a biopharmaceutical company focused on developing and commercializing medicines to improve the lives of patients with cancer. The company's pipeline targets the RAS/MAPK signaling pathway, which drives cell survival and tumor growth, through novel small molecule inhibitors. This includes KRAS G12D inhibition, RAF/MEK inhibition, and FAK inhibition to address resistance mechanisms. Verastem achieved an FDA-approved treatment (AVMAPKI FAKZYNJA CO-PACK) for KRAS-mutant recurrent low-grade serous ovarian cancer, the first approved therapy for this indication. The company trades on NASDAQ under the symbol VSTM.

Summary

It lists 51–200 employees. It has raised $392.5M in total across 8 rounds, most recently a $90.0M Corporate Round in Nov 2025. Investors include Bessemer Venture Partners, Advanced Technology Ventures and MPM Capital.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
Corporate RoundCorporate RoundNov 2025
$90.0M

Sign up to see all 10 events

Funding: Series A through Corporate Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Verastem on Indexed.vc
<a href="https://indexed.vc/companies/verastem"><img src="https://indexed.vc/api/badge/company/verastem" alt="Verastem on Indexed.vc" width="260" height="76" /></a>